SANOFI NAMES ARCHANA SUBRAMANYA R&D INDIA HEAD

Sanofi has appointed Archana Subramanya as Head of its R&D India Hub—a signal that pharma majors are deepening research operations in India, not just manufacturing or support functions.

This mirrors a 3-year trend: global pharma is shifting early-stage drug discovery and clinical research closer to talent pools and regulatory expertise in Asia. India's R&D hubs now compete with onshore centers for strategic work.

📍 For GCC professionals: R&D leadership roles demand a different skill stack than traditional GCC ops—regulatory knowledge, scientific credibility, and P&L ownership matter more. GCC ERA tracks 1,800+ centers; R&D hubs are the fastest-growing vertical.

Are you seeing R&D roles open up in your organization?

Source: Sanofi Appoints Archana Subramanya as Head – R&D India Hub - hrtoday.in

#Sanofi #R&D #Pharma #GCCERA #Hyderabad